| 摘要 |
<p>FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to medicine, particularly to antiviral agents. What is offered is application as an antiviral agent for treating ARVI, including influenza, of soapy amphiphilic high-polymer RNA Saccharomyces cerevisiae recovered from dry baker's yeast with the use of alkali titred oleic acid, or with the use of sodium dodecyl sulphate by processing of the recovered RNA with oleic acid (the proposed market name of the agent is Vitalang-2). The antiviral properties of the agent have been tested at the time of influenza epidemic, and a positive result has been shown positive. ^ EFFECT: low-toxic properties of the agent and reduced time for treating the ARVI to 1 day are shown.</p> |
